Combination drugs

Last Updated on 29th August, 2024
1 minute, 53 seconds

Description

Disclaimer: Copyright infringement not intended.

Context:

  • The government has banned 156 fixed-dose combination (FDC) drugs, including popular medicines such as Cheston Cold and Foracet, used for cold and fever and pain respectively.
  • The recent ban represents the most extensive crackdown on fixed-dose combinations (FDCs) — which are single-dosage forms containing two or more drugs — since 2018, when 328 FDCs were prohibited. In total, 499 FDCs have been banned since 2014.

About Combination Drugs:

When two or more drugs are combined in a fixed ratio into a single dosage form, it is termed as fixed dose combination (FDC). They are not only intended for fever and cold but also as anti-hypertensives, where the combination drug addresses both blood pressure and cholesterol.

READ IN DETAIL-

https://www.iasgyan.in/daily-current-affairs/fixed-dose-combination-drugs#:~:text=Fixed%20Dose%20Combination%20(FDC)%20drugs,multiple%20symptoms%20or%20conditions%20simultaneously.

https://indianexpress.com/article/explained/explained-health/govt-ban-fdc-drugs-cheston-cold-foracet-health-ministry-fever-allergies-aches-9536556/ 

PRACTICE QUESTION

Q. Which of the following statements about fixed-dose combination (FDC) drugs is/are correct?

  1. FDCs are combinations of two or more drugs in a single dosage form.
  2. The ban on FDCs in India was first implemented in 2014.
  3. FDCs are intended to simplify drug regimens and improve patient compliance.
  4. The safety and efficacy of FDCs are always guaranteed by regulatory authorities without further testing.

Select the correct answer using the codes below:

A. 1 and 2

B. 1 and 3

C. 2 and 4

D. 1, 3, and 4

Answer: B

Related Articles

CENTRIFUGE 03 Apr, 2025
XENOTRANSPLANTION 02 Apr, 2025
SILVAGUARD DRONE 02 Apr, 2025
COELIAC DISEASE 02 Apr, 2025
BISAG N 01 Apr, 2025
GSAT 18 29 Mar, 2025
AMORE EXPERIMENT 29 Mar, 2025
GAIA 29 Mar, 2025

Free access to e-paper and WhatsApp updates

Let's Get In Touch!